Health
Belgium nominates Hans Kluge as WHO Director General
The Belgian federal government has nominated Hans Kluge (pictured) for the position of Director-General of the World Health Organization (WHO).
“I am very honoured by the trust Belgium has placed in me and am grateful for the opportunity to take on this important responsibility,” Kluge said on X. “Serving the WHO has been the greatest privilege of my professional life.”
Kluge has served as WHO Regional Director for Europe since 2020 and began a second term in February 2025. Under WHO rules, he will step aside as WHO/Europe Director while campaigning for the role, a process that involves lobbying member states, NGOs and the organisation's largest funders.
Tried and tested
After qualifying as a doctor in Belgium, he began his international career with Médecins Sans Frontières in conflict settings in Liberia and Somalia. He subsequently coordinated tuberculosis programmes in Siberian prisons and across the former Soviet Union.
Kluge joined WHO in 1999, initially working on tuberculosis and HIV in...

Share this article:
EU Reporter publishes articles from a variety of outside sources which express a wide range of viewpoints. The positions taken in these articles are not necessarily those of EU Reporter. Please see EU Reporter’s full Terms and Conditions of publication for more information EU Reporter embraces artificial intelligence as a tool to enhance journalistic quality, efficiency, and accessibility, while maintaining strict human editorial oversight, ethical standards, and transparency in all AI-assisted content. Please see EU Reporter’s full A.I. Policy for more information.
-
Kazakhstan1 day agoFrom oil reserves to infrastructure: How Kazakhstan invests in future generations
-
Sport3 days agoGurbanguly Berdimuhamedov attends World Championship of Akhal-Teke horses in the Netherlands
-
Animal welfare3 days agoLeading scientists and experts in 'The Lancet' urge EU to ban fur farming over public health risks
-
Economic governance12 hours agoTavira custody businesses face scrutiny following regulatory action and disputed civil claim
